ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Olaparib API Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-10G18687
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Olaparib API Market Research Report 2024
BUY CHAPTERS

Global Olaparib API Market Research Report 2024

Code: QYRE-Auto-10G18687
Report
November 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Transo-Pharm USA LLC
ALP Pharm Beijing
MSN Laboratories
Alembic Pharmaceuticals
Exelixis Inc
Pfizer Inc
Astrazeneca plc
Novartis
Bayer
Dr. Reddy’s Laboratories
ScinoPham Taiwan
Sun Pharmaceutical Industrial

Olaparib API Market Size

The global Olaparib API market was valued at US$ 928 million in 2023 and is anticipated to reach US$ 2514 million by 2030, witnessing a CAGR of 15.3% during the forecast period 2024-2030.

Olaparib API Market

Olaparib API Market

Olaparib API refers to the active pharmaceutical ingredient (API) in medications containing olaparib, a drug used primarily in cancer treatment. Olaparib is a PARP (poly ADP-ribose polymerase) inhibitor, which works by blocking PARP enzymes involved in DNA repair. This inhibition is particularly effective in cancer cells with BRCA1 or BRCA2 mutations, as these cells rely heavily on PARP for repair. By inhibiting PARP, olaparib causes DNA damage to accumulate in cancer cells, leading to cell death.
North American market for Olaparib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Olaparib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Olaparib API include ScinoPham Taiwan, Transo-Pharm USA LLC, ALP Pharm Beijing, MSN Laboratories, Alembic Pharmaceuticals, Exelixis, Pfizer, AstraZeneca, Novartis AG, Bayer AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Olaparib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olaparib API.
The Olaparib API market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Olaparib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olaparib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Olaparib API Market Report

Report Metric Details
Report Name Olaparib API Market
Accounted market size in 2023 US$ 928 million
Forecasted market size in 2030 US$ 2514 million
CAGR 15.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Pharmaceuticals
  • Biomedical
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ScinoPham Taiwan, Transo-Pharm USA LLC, ALP Pharm Beijing, MSN Laboratories, Alembic Pharmaceuticals, Exelixis, Pfizer, AstraZeneca, Novartis AG, Bayer AG, DR. Reddy's Laboratories, Sun Pharmaceutical Industrial
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Olaparib API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Olaparib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Olaparib API Market growing?

Ans: The Olaparib API Market witnessing a CAGR of 15.3% during the forecast period 2024-2030.

What is the Olaparib API Market size in 2030?

Ans: The Olaparib API Market size in 2030 will be US$ 2514 million.

Who are the main players in the Olaparib API Market report?

Ans: The main players in the Olaparib API Market are ScinoPham Taiwan, Transo-Pharm USA LLC, ALP Pharm Beijing, MSN Laboratories, Alembic Pharmaceuticals, Exelixis, Pfizer, AstraZeneca, Novartis AG, Bayer AG, DR. Reddy's Laboratories, Sun Pharmaceutical Industrial

What are the Application segmentation covered in the Olaparib API Market report?

Ans: The Applications covered in the Olaparib API Market report are Pharmaceuticals, Biomedical, Others

What are the Type segmentation covered in the Olaparib API Market report?

Ans: The Types covered in the Olaparib API Market report are Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer

Recommended Reports

Cancer APIs

PARP Inhibition

General API Markets

1 Olaparib API Market Overview
1.1 Product Definition
1.2 Olaparib API by Type
1.2.1 Global Olaparib API Market Value Comparison by Type (2024-2030)
1.2.2 Ovarian Cancer
1.2.3 Breast Cancer
1.2.4 Pancreatic Cancer
1.2.5 Prostate Cancer
1.3 Olaparib API by Application
1.3.1 Global Olaparib API Market Value by Application (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Biomedical
1.3.4 Others
1.4 Global Olaparib API Market Size Estimates and Forecasts
1.4.1 Global Olaparib API Revenue 2019-2030
1.4.2 Global Olaparib API Sales 2019-2030
1.4.3 Global Olaparib API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Olaparib API Market Competition by Manufacturers
2.1 Global Olaparib API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Olaparib API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Olaparib API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Olaparib API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Olaparib API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Olaparib API, Product Type & Application
2.7 Global Key Manufacturers of Olaparib API, Date of Enter into This Industry
2.8 Global Olaparib API Market Competitive Situation and Trends
2.8.1 Global Olaparib API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Olaparib API Players Market Share by Revenue
2.8.3 Global Olaparib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Olaparib API Market Scenario by Region
3.1 Global Olaparib API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Olaparib API Sales by Region: 2019-2030
3.2.1 Global Olaparib API Sales by Region: 2019-2024
3.2.2 Global Olaparib API Sales by Region: 2025-2030
3.3 Global Olaparib API Revenue by Region: 2019-2030
3.3.1 Global Olaparib API Revenue by Region: 2019-2024
3.3.2 Global Olaparib API Revenue by Region: 2025-2030
3.4 North America Olaparib API Market Facts & Figures by Country
3.4.1 North America Olaparib API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Olaparib API Sales by Country (2019-2030)
3.4.3 North America Olaparib API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Olaparib API Market Facts & Figures by Country
3.5.1 Europe Olaparib API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Olaparib API Sales by Country (2019-2030)
3.5.3 Europe Olaparib API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Olaparib API Market Facts & Figures by Region
3.6.1 Asia Pacific Olaparib API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Olaparib API Sales by Region (2019-2030)
3.6.3 Asia Pacific Olaparib API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Olaparib API Market Facts & Figures by Country
3.7.1 Latin America Olaparib API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Olaparib API Sales by Country (2019-2030)
3.7.3 Latin America Olaparib API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Olaparib API Market Facts & Figures by Country
3.8.1 Middle East and Africa Olaparib API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Olaparib API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Olaparib API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Olaparib API Sales by Type (2019-2030)
4.1.1 Global Olaparib API Sales by Type (2019-2024)
4.1.2 Global Olaparib API Sales by Type (2025-2030)
4.1.3 Global Olaparib API Sales Market Share by Type (2019-2030)
4.2 Global Olaparib API Revenue by Type (2019-2030)
4.2.1 Global Olaparib API Revenue by Type (2019-2024)
4.2.2 Global Olaparib API Revenue by Type (2025-2030)
4.2.3 Global Olaparib API Revenue Market Share by Type (2019-2030)
4.3 Global Olaparib API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Olaparib API Sales by Application (2019-2030)
5.1.1 Global Olaparib API Sales by Application (2019-2024)
5.1.2 Global Olaparib API Sales by Application (2025-2030)
5.1.3 Global Olaparib API Sales Market Share by Application (2019-2030)
5.2 Global Olaparib API Revenue by Application (2019-2030)
5.2.1 Global Olaparib API Revenue by Application (2019-2024)
5.2.2 Global Olaparib API Revenue by Application (2025-2030)
5.2.3 Global Olaparib API Revenue Market Share by Application (2019-2030)
5.3 Global Olaparib API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ScinoPham Taiwan
6.1.1 ScinoPham Taiwan Company Information
6.1.2 ScinoPham Taiwan Description and Business Overview
6.1.3 ScinoPham Taiwan Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ScinoPham Taiwan Olaparib API Product Portfolio
6.1.5 ScinoPham Taiwan Recent Developments/Updates
6.2 Transo-Pharm USA LLC
6.2.1 Transo-Pharm USA LLC Company Information
6.2.2 Transo-Pharm USA LLC Description and Business Overview
6.2.3 Transo-Pharm USA LLC Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Transo-Pharm USA LLC Olaparib API Product Portfolio
6.2.5 Transo-Pharm USA LLC Recent Developments/Updates
6.3 ALP Pharm Beijing
6.3.1 ALP Pharm Beijing Company Information
6.3.2 ALP Pharm Beijing Description and Business Overview
6.3.3 ALP Pharm Beijing Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ALP Pharm Beijing Olaparib API Product Portfolio
6.3.5 ALP Pharm Beijing Recent Developments/Updates
6.4 MSN Laboratories
6.4.1 MSN Laboratories Company Information
6.4.2 MSN Laboratories Description and Business Overview
6.4.3 MSN Laboratories Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MSN Laboratories Olaparib API Product Portfolio
6.4.5 MSN Laboratories Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Company Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alembic Pharmaceuticals Olaparib API Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Exelixis
6.6.1 Exelixis Company Information
6.6.2 Exelixis Description and Business Overview
6.6.3 Exelixis Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Exelixis Olaparib API Product Portfolio
6.6.5 Exelixis Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Pfizer Olaparib API Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Olaparib API Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Company Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novartis AG Olaparib API Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Company Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer AG Olaparib API Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 DR. Reddy's Laboratories
6.11.1 DR. Reddy's Laboratories Company Information
6.11.2 DR. Reddy's Laboratories Description and Business Overview
6.11.3 DR. Reddy's Laboratories Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 DR. Reddy's Laboratories Olaparib API Product Portfolio
6.11.5 DR. Reddy's Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical Industrial
6.12.1 Sun Pharmaceutical Industrial Company Information
6.12.2 Sun Pharmaceutical Industrial Description and Business Overview
6.12.3 Sun Pharmaceutical Industrial Olaparib API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sun Pharmaceutical Industrial Olaparib API Product Portfolio
6.12.5 Sun Pharmaceutical Industrial Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Olaparib API Industry Chain Analysis
7.2 Olaparib API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Olaparib API Production Mode & Process
7.4 Olaparib API Sales and Marketing
7.4.1 Olaparib API Sales Channels
7.4.2 Olaparib API Distributors
7.5 Olaparib API Customers
8 Olaparib API Market Dynamics
8.1 Olaparib API Industry Trends
8.2 Olaparib API Market Drivers
8.3 Olaparib API Market Challenges
8.4 Olaparib API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Transo-Pharm USA LLC
ALP Pharm Beijing
MSN Laboratories
Alembic Pharmaceuticals
Exelixis Inc
Pfizer Inc
Astrazeneca plc
Novartis
Bayer
Dr. Reddy’s Laboratories
ScinoPham Taiwan
Sun Pharmaceutical Industrial
List of Tables
 Table 1. Global Olaparib API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Olaparib API Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Olaparib API Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Olaparib API Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global Olaparib API Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Olaparib API Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Olaparib API Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Olaparib API Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Olaparib API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Olaparib API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Olaparib API, Product Type & Application
 Table 12. Global Key Manufacturers of Olaparib API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Olaparib API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olaparib API as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Olaparib API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Olaparib API Sales by Region (2019-2024) & (kg)
 Table 18. Global Olaparib API Sales Market Share by Region (2019-2024)
 Table 19. Global Olaparib API Sales by Region (2025-2030) & (kg)
 Table 20. Global Olaparib API Sales Market Share by Region (2025-2030)
 Table 21. Global Olaparib API Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Olaparib API Revenue Market Share by Region (2019-2024)
 Table 23. Global Olaparib API Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Olaparib API Revenue Market Share by Region (2025-2030)
 Table 25. North America Olaparib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Olaparib API Sales by Country (2019-2024) & (kg)
 Table 27. North America Olaparib API Sales by Country (2025-2030) & (kg)
 Table 28. North America Olaparib API Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Olaparib API Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Olaparib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Olaparib API Sales by Country (2019-2024) & (kg)
 Table 32. Europe Olaparib API Sales by Country (2025-2030) & (kg)
 Table 33. Europe Olaparib API Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Olaparib API Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Olaparib API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Olaparib API Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific Olaparib API Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific Olaparib API Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Olaparib API Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Olaparib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Olaparib API Sales by Country (2019-2024) & (kg)
 Table 42. Latin America Olaparib API Sales by Country (2025-2030) & (kg)
 Table 43. Latin America Olaparib API Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Olaparib API Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Olaparib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Olaparib API Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa Olaparib API Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa Olaparib API Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Olaparib API Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Olaparib API Sales (kg) by Type (2019-2024)
 Table 51. Global Olaparib API Sales (kg) by Type (2025-2030)
 Table 52. Global Olaparib API Sales Market Share by Type (2019-2024)
 Table 53. Global Olaparib API Sales Market Share by Type (2025-2030)
 Table 54. Global Olaparib API Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Olaparib API Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Olaparib API Revenue Market Share by Type (2019-2024)
 Table 57. Global Olaparib API Revenue Market Share by Type (2025-2030)
 Table 58. Global Olaparib API Price (US$/g) by Type (2019-2024)
 Table 59. Global Olaparib API Price (US$/g) by Type (2025-2030)
 Table 60. Global Olaparib API Sales (kg) by Application (2019-2024)
 Table 61. Global Olaparib API Sales (kg) by Application (2025-2030)
 Table 62. Global Olaparib API Sales Market Share by Application (2019-2024)
 Table 63. Global Olaparib API Sales Market Share by Application (2025-2030)
 Table 64. Global Olaparib API Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Olaparib API Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Olaparib API Revenue Market Share by Application (2019-2024)
 Table 67. Global Olaparib API Revenue Market Share by Application (2025-2030)
 Table 68. Global Olaparib API Price (US$/g) by Application (2019-2024)
 Table 69. Global Olaparib API Price (US$/g) by Application (2025-2030)
 Table 70. ScinoPham Taiwan Company Information
 Table 71. ScinoPham Taiwan Description and Business Overview
 Table 72. ScinoPham Taiwan Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. ScinoPham Taiwan Olaparib API Product
 Table 74. ScinoPham Taiwan Recent Developments/Updates
 Table 75. Transo-Pharm USA LLC Company Information
 Table 76. Transo-Pharm USA LLC Description and Business Overview
 Table 77. Transo-Pharm USA LLC Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. Transo-Pharm USA LLC Olaparib API Product
 Table 79. Transo-Pharm USA LLC Recent Developments/Updates
 Table 80. ALP Pharm Beijing Company Information
 Table 81. ALP Pharm Beijing Description and Business Overview
 Table 82. ALP Pharm Beijing Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. ALP Pharm Beijing Olaparib API Product
 Table 84. ALP Pharm Beijing Recent Developments/Updates
 Table 85. MSN Laboratories Company Information
 Table 86. MSN Laboratories Description and Business Overview
 Table 87. MSN Laboratories Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. MSN Laboratories Olaparib API Product
 Table 89. MSN Laboratories Recent Developments/Updates
 Table 90. Alembic Pharmaceuticals Company Information
 Table 91. Alembic Pharmaceuticals Description and Business Overview
 Table 92. Alembic Pharmaceuticals Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. Alembic Pharmaceuticals Olaparib API Product
 Table 94. Alembic Pharmaceuticals Recent Developments/Updates
 Table 95. Exelixis Company Information
 Table 96. Exelixis Description and Business Overview
 Table 97. Exelixis Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. Exelixis Olaparib API Product
 Table 99. Exelixis Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. Pfizer Olaparib API Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. AstraZeneca Olaparib API Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Novartis AG Company Information
 Table 111. Novartis AG Description and Business Overview
 Table 112. Novartis AG Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 113. Novartis AG Olaparib API Product
 Table 114. Novartis AG Recent Developments/Updates
 Table 115. Bayer AG Company Information
 Table 116. Bayer AG Description and Business Overview
 Table 117. Bayer AG Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 118. Bayer AG Olaparib API Product
 Table 119. Bayer AG Recent Developments/Updates
 Table 120. DR. Reddy's Laboratories Company Information
 Table 121. DR. Reddy's Laboratories Description and Business Overview
 Table 122. DR. Reddy's Laboratories Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 123. DR. Reddy's Laboratories Olaparib API Product
 Table 124. DR. Reddy's Laboratories Recent Developments/Updates
 Table 125. Sun Pharmaceutical Industrial Company Information
 Table 126. Sun Pharmaceutical Industrial Description and Business Overview
 Table 127. Sun Pharmaceutical Industrial Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 128. Sun Pharmaceutical Industrial Olaparib API Product
 Table 129. Sun Pharmaceutical Industrial Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Olaparib API Distributors List
 Table 133. Olaparib API Customers List
 Table 134. Olaparib API Market Trends
 Table 135. Olaparib API Market Drivers
 Table 136. Olaparib API Market Challenges
 Table 137. Olaparib API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Olaparib API
 Figure 2. Global Olaparib API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Olaparib API Market Share by Type: 2023 & 2030
 Figure 4. Ovarian Cancer Product Picture
 Figure 5. Breast Cancer Product Picture
 Figure 6. Pancreatic Cancer Product Picture
 Figure 7. Prostate Cancer Product Picture
 Figure 8. Global Olaparib API Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Olaparib API Market Share by Application: 2023 & 2030
 Figure 10. Pharmaceuticals
 Figure 11. Biomedical
 Figure 12. Others
 Figure 13. Global Olaparib API Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Olaparib API Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Olaparib API Sales (2019-2030) & (kg)
 Figure 16. Global Olaparib API Average Price (US$/g) & (2019-2030)
 Figure 17. Olaparib API Report Years Considered
 Figure 18. Olaparib API Sales Share by Manufacturers in 2023
 Figure 19. Global Olaparib API Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Olaparib API Players: Market Share by Revenue in Olaparib API in 2023
 Figure 21. Olaparib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Olaparib API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Olaparib API Sales Market Share by Country (2019-2030)
 Figure 24. North America Olaparib API Revenue Market Share by Country (2019-2030)
 Figure 25. United States Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Olaparib API Sales Market Share by Country (2019-2030)
 Figure 28. Europe Olaparib API Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Olaparib API Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Olaparib API Revenue Market Share by Region (2019-2030)
 Figure 36. China Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Olaparib API Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Olaparib API Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Olaparib API Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Olaparib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Olaparib API by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Olaparib API by Type (2019-2030)
 Figure 55. Global Olaparib API Price (US$/g) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Olaparib API by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Olaparib API by Application (2019-2030)
 Figure 58. Global Olaparib API Price (US$/g) by Application (2019-2030)
 Figure 59. Olaparib API Value Chain
 Figure 60. Olaparib API Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Niraparib API Market Research Report 2024
Global PARP Poly ADP Ribose Polymerase Inhibitor Market Research Report 2025
Prostate Cancer PARP Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Niraparib Preparations Market Research Report 2024
Global PARP Poly ADP ribose Polymerase Inhibitors Market Insights Forecast to 2030
Global Oncology API Market Research Report 2024
Global Ceritinib API Market Research Report 2024
PARP Inhibitors for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Drug based on PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Crizotinib API Market Research Report 2024
Global Icotinib API Market Research Report 2024
Global Brigatinib API Market Research Report 2024
Global Poly ADP Ribose Polymerase PARP Inhibitors Market Research Report 2024
Global Olaparib Market Research Report 2024
Global Afatinib API Market Research Report 2024
Global PARP Inhibitors for Breast Cancer Market Research Report 2024
Global Anastrozole APl Market Research Report 2024
Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pazopanib API Market Research Report 2025
Global Oseltamivir Phosphate API Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions